Table 5.
KEGG pathway for dose-dependent significantly differentiating proteins.
| GO ID | Term | Number of Genes | p-value |
|---|---|---|---|
| 4614 | Renin-angiotensin system | 2 | 6.00E-04 |
| 5010 | Alzheimer's disease | 4 | 6.48E-04 |
| 270 | Cysteine and methionine metabolism | 2 | 3.02E-03 |
| 620 | Pryruvate metabolism | 2 | 4.77E-03 |
| 1120 | Microbial metabolism in diverse environments | 3 | 4.99E-03 |
| 4610 | Complement of coagulation cascades | 2 | 7.85E-03 |
| 5412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 2 | 8.60E-03 |
| 5205 | Proteoglycans in cancer | 3 | 9.68E-03 |
| 1100 | Metabolic pathways | 7 | 1.01E-02 |
| 10 | Glycolysis/Gluconeogenesis | 2 | 1.07E-02 |
| 4974 | Protein digestion and absorption | 2 | 1.25E-02 |
| 1200 | Carbon metabolism | 2 | 2.29E-02 |
| 4514 | Cell adhesion molecules (CAMs) | 2 | 3.36E-02 |
| 5161 | Hepatitis B | 2 | 3.78E-02 |
| 5012 | Parkinson's disease | 2 | 4.84E-02 |